WithdrawnPhase 4

Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

Stopped: Time constraints of primary investigator.

United States0Started 2013-08

Plain-language summary

Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide adequate glycemic control. Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help maintain euglycemia for pregnant patients with gestational and preexisting diabetes after steroid administration, and possibly impact length of hospital admission.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pregnant women with gestational or pre-existing diabetes admitted to the University of Minnesota
✓. Must be 18 years or older
✓. Must speak English, Spanish, or Somali
✓. Patients must receive steroids for fetal lung maturity as part of their hospital course

Exclusion criteria

✕. Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ disease
✕. Pregnant women who need to be emergently delivered due to maternal or fetal complications of pregnancy

What they're measuring

Number of hospital days until euglycemia in pregnant diabetic patients receiving steroids who are pre-treated with insulin.

Timeframe: number of hospital days

Trial details

NCT IDNCT01875107

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-08

View on ClinicalTrials.gov More Hyperglycemia in Pregnant Diabetic Patients trials